Literature DB >> 23255526

Children's Oncology Group's 2013 blueprint for research: radiation oncology.

Thomas E Merchant1, David Hodgson, Nadia N I Laack, Suzanne Wolden, Danny J Indelicato, John A Kalapurakal.   

Abstract

Radiation therapy (RT) is used to treat children with CNS tumors, solid tumors or Hodgkin lymphoma. Pediatric radiation oncologists have provided critical input into the development and implementation of concepts for clinical trials to further define the modality's role and test newer methods to reduce side effects or intensify therapy. The quality of pediatric oncology clinical trials that include radiation therapy is linked to the quality of guidelines. Radiation oncology is an adult medical specialty; thus, pediatric radiation oncologists are uniquely positioned to work with adult cancer investigators in the reorganized US National Cancer Institute Clinic Trials Network.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2012        PMID： 23255526      PMCID： PMC4709221          DOI： 10.1002/pbc.24425

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  22 in total

1.  POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.

Authors:  Faith H Kung; Cindy L Schwartz; Carolyn R Ferree; Wendy B London; Jessie L Ternberg; Fred G Behm; Moody D Wharam; John M Falletta; Pedro de Alarcon; Allen R Chauvenet
Journal:  J Pediatr Hematol Oncol       Date:  2006-06       Impact factor: 1.289

2.  Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma.

Authors:  Thomas E Merchant; Erin N Kiehna; Chenghong Li; Hemant Shukla; Saikat Sengupta; Xiaoping Xiong; Amar Gajjar; Raymond K Mulhern
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-02-10       Impact factor: 7.038

3.  Cardiac-sparing whole lung IMRT in children with lung metastasis.

Authors:  John A Kalapurakal; Yunkai Zhang; Alan Kepka; Brian Zawislak; Vythialingam Sathiaseelan; Cynthia Rigsby; Mahesh Gopalakrishnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-18       Impact factor: 7.038

4.  Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.

Authors:  Torunn I Yock; Mark Krailo; Christopher J Fryer; Sarah S Donaldson; James S Miser; Zhengjia Chen; Mark Bernstein; Fran Laurie; Mark C Gebhardt; Holcombe E Grier; Nancy J Tarbell
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

5.  Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

Authors:  Holcombe E Grier; Mark D Krailo; Nancy J Tarbell; Michael P Link; Christopher J H Fryer; Douglas J Pritchard; Mark C Gebhardt; Paul S Dickman; Elizabeth J Perlman; Paul A Meyers; Sarah S Donaldson; Sheila Moore; Aaron R Rausen; Teresa J Vietti; James S Miser
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

6.  Estimating differences in volumetric flat bone growth in pediatric patients by radiation treatment method.

Authors:  Chiaho Hua; Hemant I Shukla; Thomas E Merchant; Matthew J Krasin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-09       Impact factor: 7.038

7.  Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.

Authors:  D M Green; Y A Grigoriev; B Nan; J R Takashima; P A Norkool; G J D'Angio; N E Breslow
Journal:  J Clin Oncol       Date:  2001-04-01       Impact factor: 44.544

8.  Differential attenuation of clavicle growth after asymmetric mantle radiotherapy.

Authors:  Thomas E Merchant; Lan Nguyen; Duyen Nguyen; Shengje Wu; Melissa M Hudson; Sue C Kaste
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

9.  Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.

Authors:  Linda Granowetter; Richard Womer; Meenakshi Devidas; Mark Krailo; Chenguang Wang; Mark Bernstein; Neyssa Marina; Patrick Leavey; Mark Gebhardt; John Healey; Robert Cooper Shamberger; Allen Goorin; James Miser; James Meyer; Carola A S Arndt; Scott Sailer; Karen Marcus; Elizabeth Perlman; Paul Dickman; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

10.  Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.

Authors:  R G Grundy; S H Wilne; K J Robinson; J W Ironside; T Cox; W K Chong; A Michalski; R H A Campbell; C C Bailey; N Thorp; B Pizer; J Punt; D A Walker; D W Ellison; D Machin
Journal:  Eur J Cancer       Date:  2010-01       Impact factor: 9.162
View more
  6 in total

1.  Trajectories of psychosocial and cognitive functioning in pediatric patients with brain tumors treated with radiation therapy.

Authors:  Victoria W Willard; Kristoffer S Berlin; Heather M Conklin; Thomas E Merchant
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

2.  Reduced-volume radiotherapy for patients with localized intracranial nongerminoma germ cell tumors.

Authors:  Brian De; Oren Cahlon; Ira J Dunkel; Kevin C De Braganca; Yasmin Khakoo; Stephen W Gilheeney; Mark M Souweidane; Suzanne L Wolden
Journal:  J Neurooncol       Date:  2017-06-28       Impact factor: 4.130

Review 3.  Proton therapy for the treatment of children with CNS malignancies.

Authors:  Radhika Sreeraman; Daniel J Indelicato
Journal:  CNS Oncol       Date:  2014-03

4.  Patterns of relapse for children with localized intracranial ependymoma.

Authors:  Brian De; Yasmin Khakoo; Mark M Souweidane; Ira J Dunkel; Suchit H Patel; Stephen W Gilheeney; Kevin C De Braganca; Matthias A Karajannis; Suzanne L Wolden
Journal:  J Neurooncol       Date:  2018-03-06       Impact factor: 4.130

5.  Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.

Authors:  Hubert Y Pan; Ajaykumar Morani; Wei-Lien Wang; Kenneth R Hess; Arnold C Paulino; Joseph A Ludwig; Patrick P Lin; Najat C Daw; Anita Mahajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-03-12       Impact factor: 7.038

6.  Surveillance for radiation-related late effects in childhood cancer survivors: The impact of using volumetric dosimetry.

Authors:  Sally Cohen-Cutler; Arthur Olch; Kenneth Wong; Jemily Malvar; Richard Sposto; Pierre Kobierski; Amit Sura; Louis S Constine; David R Freyer
Journal:  Cancer Med       Date:  2020-12-16       Impact factor: 4.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.